English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR
  • Contact
  • Careers
  • English
  • Français

Press Releases

News

News

  • Press Releases
  • Events
Jun 28, 2021 4:30pm EDT

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

Jun 16, 2021 5:00pm EDT

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Jun 15, 2021 4:05pm EDT

Medexus Announces Graduation to the Toronto Stock Exchange

Jun 14, 2021 8:30am EDT

Medexus to Present at Raymond James Human Health Innovation Conference

Jun 11, 2021 8:30am EDT

Medexus Schedules Fiscal Year 2021 Conference Call

Jun 10, 2021 8:30am EDT

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

Jun 09, 2021 8:30am EDT

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

Jun 01, 2021 8:30am EDT

Medexus to Present at The LD Micro Virtual Invitational XI on June 8th

May 27, 2021 5:00pm EDT

Medexus Announces Amendments to its Credit Agreements

May 12, 2021 8:30am EDT

Medexus to Present at the Sidoti & Company Virtual Microcap Conference on May 19th

RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...13
    Next
    © 2023 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.